REPORT FROM THE 63rd ANNUAL MEETING OF THE AMERICAN ACADEMY OF NEUROLOGY (AAN), HONOLULU, HAWAII, APRIL 9-16, 2011 – MS patients are inclined to accept new therapies regardless of the potential risks, according to a survey conducted by Wayne State University in the period 2007-2009 (Caon et al AAN 2011; abstract P01.208).